Grayscale Intervention & Diagnostics Center Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-05-2024
- Paid Up Capital ₹ 0.10 M
as on 22-05-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 74.20 M
as on 22-05-2024
- Satisfied Charges ₹ 179.00 M
as on 22-05-2024
- Revenue 153.96%
(FY 2022)
- Profit 149.20%
(FY 2022)
- Ebitda 297.63%
(FY 2022)
- Net Worth 245.03%
(FY 2022)
- Total Assets 11.48%
(FY 2022)
About Grayscale Intervention & Diagnostics Center
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹7.42 Cr. The company has closed loans amounting to ₹17.90 Cr, as per Ministry of Corporate Affairs (MCA) records.
Geeta Chandra and Tripti Shah serve as directors at the Company.
- CIN/LLPIN
U85300RJ2020PTC068381
- Company No.
068381
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Grayscale Intervention & Diagnostics Center?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geeta Chandra  | Director | 26-Feb-2020 | Current |
| Tripti Shah | Director | 26-Feb-2020 | Current |
Financial Performance and Corporate Structure Insights of Grayscale Intervention & Diagnostics Center.
Grayscale Intervention & Diagnostics Center Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 153.96% increase. The company also saw a substantial improvement in profitability, with a 149.2% increase in profit. The company's net worth Soared by an impressive increase of 245.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Grayscale Intervention & Diagnostics Center?
In 2021, Grayscale Intervention & Diagnostics Center had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Feb 2022 | ₹7.42 Cr | Open |
Others Creation Date: 22 Mar 2021 | ₹9.90 Cr | Satisfied |
Others Creation Date: 10 Feb 2021 | ₹8.00 Cr | Satisfied |
How Many Employees Work at Grayscale Intervention & Diagnostics Center?
Unlock and access historical data on people associated with Grayscale Intervention & Diagnostics Center, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Grayscale Intervention & Diagnostics Center, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Grayscale Intervention & Diagnostics Center's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
